Therapeutic index improvement of antibody-drug conjugates

The commentary by Colombo and Rich recently published in Cancer Cell provides a timely and comprehensive review of the clinical maximum tolerated doses (MTDs) of antibody−drug conjugates (ADCs) and their corresponding small molecules/chemotherapies. The authors identified similarities between their...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, Hans-Peter, Gangwar, Sanjeev, Betts, Alison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324427/
https://www.ncbi.nlm.nih.gov/pubmed/37408311
http://dx.doi.org/10.1080/19420862.2023.2230618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324427/
https://www.ncbi.nlm.nih.gov/pubmed/37408311
http://dx.doi.org/10.1080/19420862.2023.2230618

Ejemplares similares